New drug may fight ovarian cancer
London: A new drug has offered fresh hope to ovarian cancer sufferers.
The drug Avastin can stop the spread of the disease for six months in patients whose cancer has returned.
In a trial, when patients were given it with chemotherapy and for 15 months after treatment, it stalled the cancer for six months longer than when only chemotherapy was administered.
The women saw their survival rate jump from 12 months with only chemotherapy to 18 months.
Women treated with only chemotherapy showed signs of the cancer worsening after 10 months but this jumped to 14 months with the addition of Avastin.
“We know how important it is for the success of subsequent treatment that we keep ovarian cancer under control for as long as possible after initial chemotherapy,” the Daily Express quoted oncology expert Professor Chris Poole, of University Hospital Coventry, as saying.
More from India
More from World
More from Sports
More from Entertaiment
- DNA: Beaten by mob in Kolkata, US NRI vows never to return in India
- When will democracy get freedom from dynasty politics?
- Delhi: Taxi driver dies as BMW rams into car near IIT
- DNA: Has bad time started for American 'media' after Donald Trump became US President?
- DNA: Analyzing the role of Netaji Subhash Chandra Bose in Indian Independence
- WATCH: Epic Staredown between Goldberg, The Undertaker and Brock Lesnar at WWE Raw
- Jallikattu stir: As it happened on Monday
- Naresh Agrawal breaks silence on leaving Akhilesh Yadav-led Samajwadi Party and joining BJP
- International Space Station – When, where and how to spot ISS
- Reliance Jio impact: Bharti Airtel Q3 net profit dips 54% to Rs 503.7 crore